IPA analysis match LCL
Ended Purchase Order Awarded Last action
- Contract number
- W81XWH20P0204
- Awardee
-
Qiagen, LLC UEI W2GLKC92ZH73 Part of Qiagen N.V.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $131,518
Award facts
- Opportunity
-
- Notice of Intent to Sole Source Qiagen IPA Software Special Notice · W81XWH20Q0218 · Posted Aug 26, 2020
- Contract value 100% obligated
- $131,518.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 511210 Software Publishers
- PSC
- 7030 Information Technology Software
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Germantown, MD, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $29,271 | |
| Exercise an Option | $27,877 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $26,549 | |
| Exercise an Option | $25,285 | |
| Original award | $22,536 |
About this award
The Defense Health Agency awarded Qiagen, LLC a purchase order valued at $131,518 on September 16, 2020, for Ingenuity Pathway Analysis (IPA) Match Explorer Software. This firm fixed-price contract, which has no set-aside designation, was issued as a special notice procurement opportunity and is set to conclude on September 17, 2024. The work will be performed in Germantown, Maryland, where Qiagen maintains its U.S. headquarters. IPA Match Explorer is a bioinformatics software platform used for genomic analysis and precision medicine applications, supporting the Defense Health Agency's research and diagnostic testing initiatives.
This purchase order represents a task order against Qiagen's broader relationship with the Defense Health Agency, which includes a $6.5 million Blanket Purchase Agreement for pharmaceutical products and consumables and a separate $489,895 Indefinite Delivery Contract for tuberculosis testing reagents. Qiagen, LLC is a subsidiary of Qiagen N.V., a Netherlands-based multinational biotechnology company that specializes in molecular diagnostics, genomic sequencing, and bioinformatics solutions. The company has established itself as a critical supplier to federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Veterans Affairs, and the Federal Bureau of Investigation, providing DNA/RNA extraction kits, sequencing equipment, and specialized diagnostic reagents across multiple contract vehicles.
Quick answers
Who was awarded contract W81XWH20P0204?
W81XWH20P0204 was awarded to Qiagen, LLC by Defense Health Agency (Department of Defense) on September 16, 2020.
How much is contract W81XWH20P0204 worth?
The government has obligated $131,518 on W81XWH20P0204.
Was contract W81XWH20P0204 competed?
The extent of competition for W81XWH20P0204 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award